Key Opinion Leaders (KOLs) shape medical practice and define therapeutic areas. Identifying who to work with and how to engage with them is essential for pharma and biotech companies. Based on insights from more than 50 launches and 15 different therapy areas, we have co-created with pharma and biotech companies a smart, ai enhanced platform to identify the most important KOLs, engage strategically and with full compliance.
The first six months of a product launch reliably predict its peak sales (Strategies for successful drug launches)*. Large companies and start-ups face the challenge of securing market access, ensuring product availability, building brand awareness while investing at a competitive level. With our flexible network of experts in key markets, we bring the needed capabilities and competencies to the table to ensure a timely and effective launch.
Designing and implementing patient engagement programs can prove challenging. Many programs in chronic diseases struggle to overcome low utilization and lack of sustained use. Smart use of artificial intelligence (ai), building on deep insights into the specific needs of patients and HCPs, can lead to a different quality of experience and engagement.
Digital engagement needs are on the rise, strongly accelerated by COVID. Reality, however, often reveals a staggering difference between what has been defined strategically and what can be applied in everyday use. We are combining our hands-on experience with a data-driven and practical approach to continuously optimize the results you are looking for.